JP2016516400A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516400A5 JP2016516400A5 JP2015561931A JP2015561931A JP2016516400A5 JP 2016516400 A5 JP2016516400 A5 JP 2016516400A5 JP 2015561931 A JP2015561931 A JP 2015561931A JP 2015561931 A JP2015561931 A JP 2015561931A JP 2016516400 A5 JP2016516400 A5 JP 2016516400A5
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- antigen
- binding fragment
- protein
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310082338 | 2013-03-15 | ||
| CN201310082338.1 | 2013-03-15 | ||
| PCT/CN2014/073505 WO2014139476A1 (zh) | 2013-03-15 | 2014-03-17 | Rsv融合蛋白的表位以及识别其的抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516400A JP2016516400A (ja) | 2016-06-09 |
| JP2016516400A5 true JP2016516400A5 (enExample) | 2017-03-30 |
| JP6462599B2 JP6462599B2 (ja) | 2019-01-30 |
Family
ID=51535878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015561931A Active JP6462599B2 (ja) | 2013-03-15 | 2014-03-17 | Ｒｓｖ融合タンパク質のエピトープ及びそのエピトープを認識する抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9856313B2 (enExample) |
| EP (1) | EP2975052B1 (enExample) |
| JP (1) | JP6462599B2 (enExample) |
| CN (1) | CN105722856B (enExample) |
| AU (1) | AU2014231357B2 (enExample) |
| CA (1) | CA2906960C (enExample) |
| WO (1) | WO2014139476A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2970398T (pt) | 2013-03-13 | 2024-06-07 | The Us Secretary Department Ofhealth And Human Servic | Proteínas f de pré-fusão do vsr e sua utilização |
| US9738689B2 (en) | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| CN106496324B (zh) * | 2015-11-30 | 2020-01-14 | 天津昊免生物技术有限公司 | 一种抗呼吸道合胞病毒的全人源抗体 |
| PT3439672T (pt) * | 2016-04-05 | 2021-02-24 | Janssen Vaccines & Prevention Bv | Proteína f do rsv pré-fusão solúvel e estabilizada para uso na profilaxia de infeção por rsv |
| KR102695416B1 (ko) * | 2016-10-21 | 2024-08-13 | 아디맵 엘엘씨 | 항-호흡기 세포융합 바이러스 항체, 그리고 이의 생성 방법 및 사용 방법 |
| CN118240830A (zh) * | 2016-10-26 | 2024-06-25 | 西达-赛奈医疗中心 | 中和抗tl1a单克隆抗体 |
| WO2018118754A1 (en) * | 2016-12-19 | 2018-06-28 | Vanderbilt University | Antibodies to human respiratory syncytial virus protein pre-fusion conformation and methods of use therefor |
| CN108265079A (zh) * | 2017-01-02 | 2018-07-10 | 刘昕 | 一种新型呼吸道合胞体病毒pre-F融合蛋白载体的制备方法 |
| CN113832116B (zh) * | 2017-01-12 | 2024-09-13 | 厦门大学 | 稳定呼吸道合胞病毒融合蛋白的方法 |
| SG11201908999QA (en) | 2017-04-04 | 2019-10-30 | Univ Washington | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| CA3095216A1 (en) | 2018-02-28 | 2019-09-06 | University Of Washington | Self-asssembling nanostructure vaccines |
| CN110684747B (zh) * | 2018-07-06 | 2024-05-24 | 厦门大学 | 灭活及保存呼吸道合胞病毒的方法 |
| CN111057718A (zh) * | 2018-10-17 | 2020-04-24 | 南京大学 | 一种稳定表达绿色荧光蛋白的egfp-sp2/0细胞株及其构建方法 |
| AU2020227545B2 (en) * | 2019-02-28 | 2023-10-19 | Km Biologics Co., Ltd. | RSV F/G chimeric vaccine |
| US11078242B1 (en) * | 2020-05-28 | 2021-08-03 | Sotira Covid, Llc | Peptides for Covid-19 prevention and treatment |
| WO2022268120A1 (en) * | 2021-06-22 | 2022-12-29 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Anti-rsv antibodies and uses thereof |
| CA3235979A1 (en) * | 2021-12-06 | 2023-06-15 | Xiamen University | Antibody for recognizing rsv pre-f protein and use thereof |
| CN116478296B (zh) * | 2022-10-17 | 2024-02-23 | 厦门大学 | 截短的呼吸道合胞病毒f蛋白及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5811524A (en) * | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| DE60226641D1 (de) | 2001-12-03 | 2008-06-26 | Amgen Fremont Inc | Antikörperkategorisierung auf der grundlage von bindungseigenschaften |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| AU2009353693B2 (en) | 2009-10-06 | 2016-07-21 | Medimmune Ltd | RSV-specific binding molecule |
| US8568726B2 (en) * | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| EP2591000B1 (en) * | 2010-07-09 | 2017-05-17 | Janssen Vaccines & Prevention B.V. | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| CN102210860B (zh) * | 2011-05-31 | 2012-11-21 | 昆明理工大学 | 一种结核分枝杆菌tb10．4-f1融合蛋白疫苗及制备方法 |
-
2014
- 2014-03-17 CN CN201480013927.7A patent/CN105722856B/zh active Active
- 2014-03-17 CA CA2906960A patent/CA2906960C/en active Active
- 2014-03-17 AU AU2014231357A patent/AU2014231357B2/en active Active
- 2014-03-17 US US14/777,275 patent/US9856313B2/en active Active
- 2014-03-17 WO PCT/CN2014/073505 patent/WO2014139476A1/zh not_active Ceased
- 2014-03-17 JP JP2015561931A patent/JP6462599B2/ja active Active
- 2014-03-17 EP EP14765573.2A patent/EP2975052B1/en active Active